Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.08% Nasdaq Down0.83%

Ligand Pharmaceuticals Incorporated (LGND)

-NasdaqGM
69.18 Down 1.01(1.44%) Apr 23, 4:00PM EDT
|After Hours : 69.17 Down 0.01 (0.01%) Apr 23, 5:09PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue 14,736   13,006   9,580   11,651  
Cost of Revenue1,316  2,539  1,214  663  
Gross Profit 13,420   10,467   8,366   10,988  
Operating Expenses
Research Development2,374  2,413  2,022  2,465  
Selling General and Administrative4,420  4,756  4,306  4,502  
Non Recurring201  227  523  89  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 6,425   3,071   1,515   3,932  
Income from Continuing Operations
Total Other Income/Expenses Net(4,097)(651)2,738  (1,650)
Earnings Before Interest And Taxes2,328  2,420  4,253  2,282  
Interest Expense322  394  449  912  
Income Before Tax2,006  2,026  3,804  1,370  
Income Tax Expense137  61  110  66  
Minority Interest -   -   -   -  
Net Income From Continuing Ops1,869  1,965  3,694  1,304  
Non-recurring Events
Discontinued Operations -   -  2,397  191  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 1,869   1,965   6,091   1,495  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 1,869   1,965   6,091   1,495  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.